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This study investigated the effect of ethanol extracts of Ganoderma lucidum (EGL) on the
correlation between tightening of the tight junctions (TJs) and the anti-invasive activity
in human gastric adenocarcinoma AGS cells to elucidate further the possible anticancer
mechanisms that G lucidum exerts. Within the concentrations of EGL that were not cyto-
toxic, EGL markedly inhibited the cell motility and invasiveness in a concentration-
dependent manner. The activities of matrix metalloproteinases (MMP)-2 and MMP-9 in
AGS cells were dose-dependently inhibited by treatment with EGL, and this was corre-
lated with a decrease in expression of their mRNA and proteins and the upregulation of
the expression of the tissue inhibitors of metalloproteinases. The anti-invasive activity
of EGL was also found to be associated with the increased tightness of the TJ, which
was demonstrated by an increase in transepithelial electrical resistance. Additionally,
EGL repressed the levels of the claudin family members, which are major components
of TJs that play a key role in the control and selectivity of paracellular transport. Further-
more, the levels of E-cadherin, a type I transmembrane glycoprotein, were inhibited by
EGL treatment, however, those of snail, an epithelial to mesenchymal transition regu-
lator and zinc finger transcription factor, were concentration-dependently increased in
response to EGL treatment. Although further studies are needed, the present study indi-
cates that TJs and MMPs are crucial targets of EGL-induced anti-invasiveness in human
gastric cancer AGS cells.t of Acupuncture & Moxibustion, Dongeui University College of Oriental Medicine, Busan 614-052,
on), choiyh@deu.ac.kr (Y.H. Choi)
uncture Institute
226 K.-J. Jang et al.1. Introduction
a barrier to the paracellular flux of water and solutions andMetastasis is a sequential multistep process that ultimately
leads to the outgrowth of the cancer from one organ to
another. This process involves several steps: invasion of
adjacent tissues, intravasation, transport of cancer cells
through the circulatory system, arrest at a secondary site,
extravasation, and growth in a secondary organ [1e3].
Therefore, the inhibition of tumor cell migration and
invasion are important mechanisms in the antimetastatic
properties of anticancer drugs.
Recently, the many clinical and laboratory data indicated
that the inverted expression of matrix metalloproteinases
(MMPs) and tissue inhibitors of metalloproteinases (TIMPs)
suggest that they function as key regulators in cancer inva-
sion, metastasis, and progression. MMPs are a family of zinc-
dependent endopeptidases. They are known to process
a broad spectrumof cell surfacemolecules and to function in
several important biological processes.MMPs are collectively
capable of cleaving virtually all extracellular matrix (ECM)
substrates, and thedegradation of thematrix is a keyevent in
the invasion and the metastasis of potentially malignant
lesions [4,5]. Among the various MMPs, MMP-2 and MMP-9
(known as gelatinase A and gelatinase B, respectively)
seem to play an important role in tumor invasion and
metastasis and are highly expressed in epithelial cancer
cells, including gastric carcinoma cells [6,7]. TIMPs are
naturally occurring inhibitors of MMPs. They inhibit the
catalytic activity of MMPs by binding to activated MMPs and
controlling the breakdown of the ECM [8]. TIMPs can also
inhibit proliferation, invasion, and metastasis of malignant
cells. Because disturbances in the balance between MMPs
and TIMPs can be found in various pathologic conditions,
including cancer [9], the balance between MMPs and TIMPs
plays a vital role in maintaining the integrity of healthy
tissues; MMP inhibitors, as well as TIMP activators, are ex-
pected to be useful chemotherapeutic agents for the treat-
ment of malignant cancer.
In addition, cell adhesion between neighboring epithe-
lial cells is a crucial and tightly controlled process. In
epithelial cells, several specialized and distinct intercel-
lular structures, including the gap junction, tight junction
(TJ), adherens junction (AJ), and desmosome, are respon-
sible for the establishment of contact between neighboring
cells. Among them, the most apical of these are the TJs,
which form tight seals between cells and the intercellular
space. Within a cell, TJs act as a fence that blocks the
movement of membrane proteins between the apical and
basolateral surfaces thereby maintaining the apicalebasal
polarity of the cell [10,11]. TJ strands also function as
a gate that regulates paracellular movement of ions and
small molecules between the apical and basolateral
surfaces of the layer. In precancerous lesions of the
epithelia and cancerous epithelia, TJ strands become
disorganized or lost altogether and TJs become “leaky,” as
indicated by decreased resistance to electrical current,
otherwise known as transepithelial electrical resistance
(TER), and increased paracellular permeability of the
markers [10,11]. Claudins, which are key integral
membrane proteins that form the backbone of TJs, can
form homodimers or heterodimers to produce pairedstrands between adjacent cells. The paired strands act as
the transmigration of other cells thereby determining the
characteristic permeability properties of the different
epithelial tissues [12,13]. Recent studies have provided
evidence that claudins are aberrantly expressed in various
cancers and are associated with the development and
progression of cancer, which suggests that they have key
cellular functions that are distinct from their roles in TJ-
complexes. However, the exact role of claudin over-
expression and the functional importance of these proteins
in the development of cancers remain unclear.
Many studies have indicated that mushrooms are proving
to be novel and rich sources of bioactive compounds.
Among them, Ganoderma lucidum (靈芝, lingzhi in Chinese
or reishi in Japanese) is a polypore mushroom that grows on
the lower trunks of deciduous trees. This mushroom has
been widely used in traditional Oriental medicine in tonics
for promoting longevity and health for thousands of years in
Asian countries, including China, Japan, and Korea [14e17].
The pharmacological activities of G lucidum, especially its
intrinsic immunomodulating, anti-inflammatory, and anti-
tumor properties, have been extensively documented
[17e20]. In particular, several studies have demonstrated
that various extracts of G lucidum act as anticancer agents
by interfering with the cell cycle progression, inducing
apoptosis, and suppressing angiogenesis in human cancer
cells [21e28]. However, the precise biochemical mecha-
nisms underlying G lucidum extracts-induced anti-inva-
siveness and antimetastasis have not yet been clarified.
Therefore, the present study attempted to elucidate the
antimetastatic potentials of the ethanol extracts of
G lucidum (EGL) in human gastric carcinoma AGS cells and
the underlying intracellular signal transduction pathways
involved in inhibition metastasis. The results of this study
demonstrated that EGL inhibits the cell motility and inva-
sion of AGS cells through the modulation of the activities of
MMPs and the levels of TJ-associated factors.
2. Materials and methods
2.1. Cell culture
Human gastric carcinoma AGS cells were purchased from
the American Type Culture Collection (Rockville, MD, USA).
They were cultured in RPMI 1640 medium (Gibco BRL,
Gaithersburg, MD, USA) supplemented with 10% fetal
bovine serum and 1% penicillinestreptomycin in a 37 C
incubator with 5% CO2.
2.2. Preparation of EGLs
EGLs were obtained from Dongeui University Oriental
Hospital, Busan, Korea. The freeze-dried and milled fruiting
bodies of G lucidum (200 g) were extracted with 25%
ethanol (4 L) at room temperature for 10 hours using
a blender. The extracts were filtered through a Whatman
(Maidstone, UK) #2 filter, concentrated to 500 mL under
vacuum, and then kept at e20 C [28]. The EGL solution
obtained was directly diluted in the medium before assay.
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For the cell viability study, AGS cells were grown to 70%
confluence. Then the cells were treated with various
concentrations of EGL for 48 hours. Following treatment,
cell viability was determined using the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide
(MTT, Sigma Chemical Co., St. Louis, MO, USA) assay, which
is based on the conversion of MTT to MTT-formazan by
mitochondrial enzymes.
2.4. Migration assay
For the migration assay, AGS cells were grown to conflu-
ence on 30-mm cell culture dishes coated with rat tail
collagen (20 mg/mL, BD Biosciences, Bedford, MA, USA). A
scratch was made in the cell layer with a pipette tip. After
washing with phosphate buffered saline (PBS), serum-free
media (to prevent cell proliferation) containing 0.5% or
1.0% of EGL was added. Photographs of the wounded area
were taken immediately after the scratch was made and
again 48 hours later to monitor cell movement into the
wounded area [29].
2.5. In vitro invasiveness assay
Matrigel invasion assays were used to assess the ability of
AGS cells to penetrate ECM in the presence or absence of
EGL. Briefly, cells were exposed to EGL for 6 hours, and
treated cells (50,000) were then plated onto the apical side
of the Matrigel-coated filters in serum-free medium con-
taining 0.5% or 1.0% of EGL. Medium containing 20% fetal
bovine serum was placed in the basolateral chamber to
function as a chemoattractant. After 48 hours, cells on the
apical side were wiped off with a cotton-tipped swab. Cells
on the bottom of the filter were stained with hematoxylin
and Eosin Y (Sigma) and counted (three fields of each
triplicate filter) using an inverted microscope.
2.6. Measurement of TER
TER was measured with an EVOM Epithelial Tissue Vol-
tohmmeter (World Precision Instruments, FL, USA) equip-
ped with a pair of STX-2 chopstick electrodes (World
Precision Instruments). Briefly, AGS cells were seeded into
the 8.0 mm pore-size insert (upper chamber) of a Trans-
well (Corning Costar Corp., NY, USA) and allowed to reach
full confluence after which fresh medium was replaced for
further experiments. Inserts without cells, inserts with cells
in medium, and inserts with cells with 0.5% or 1.0% of EGL
were treated for 48 hours. Electrodes were placed at the
upper and lower chambers, and the resistance was
measured with the voltohmmeter.
2.7. RNA extraction and reverse transcription
polymerase chain reaction
Total RNA was prepared using an RNeasy kit (Qiagen, La
Jolla, CA, USA) and primed with random hexamers for thesynthesis of complementary DNA with AMV reverse tran-
scriptase (Amersham Co., Arlington Heights, IL, USA),
according to the manufacturer’s instructions with DNase I
(1 U/mg RNA) pretreated total mRNA. Polymerase chain
reaction (PCR) was carried out in a Mastercycler (Eppen-
dorf, Hamburg, Germany) with the primers indicated in
Table 1. Conditions for the PCR reactions were 1 (94 C
for 3 min), 35 (94 C for 45 sec; 58 C for 45 sec; and 72 C
for 1 min), and 1 (72 C for 10 min). Amplification prod-
ucts obtained by PCR were electrophoretically separated
on a 1% agarose gel and visualized by ethidium bromide
staining.2.8. Protein extraction and western blot analysis
Total cell lysates from EGL-treated cells were prepared in
an extraction buffer: 25 mM Tris-Cl (pH 7.5), 250 mM NaCl,
5 mM ethylendiaminetetra acetic acid, 1% nonidet P-40,
0.1 mM sodium orthovanadate, 2 mg/mL leupeptin, and
100 mg/mL phenylmethylsulfonyl fluoride. Protein concen-
tration was determined using a Bio-Rad protein assay kit
(Bio-Rad, Laboratories, Hercules, CA, USA). For western
blot analysis, proteins (50 mg) were separated by 8w13%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
and then electrotransferred to a nitrocellulose membrane
(Schleicher & Schuell, Keene, NH, USA). Membranes were
blocked with 5% skim milk for 1 hour and then subjected to
immunoblot analysis with the desired antibodies. The
proteins were then visualized by the enhanced chem-
iluminescence method, according to the recommended
procedure (Amersham Co.). Primary antibodies were
purchased from Santa Cruz Biotechnology Inc. (Santa Cruz,
CA, USA) and Calbiochem (Cambridge, MA, USA).
Peroxidase-labeled donkey antirabbit immunoglobulin and
peroxidase-labeled sheep antimouse immunoglobulin were
purchased from Amersham Co.2.9. Gelatin zymographic analysis of secreted MMPs
Following incubation with various concentrations of EGL for
48 hours, cell culture supernatants were collected and
centrifuged at 400  g for 5 minutes. Cell-free supernatant
was mixed with 2X sample buffer (Invitrogen, CA, USA) and
zymography was performed using precast gels (10.0%
polyacrylamide and 0.1% gelatin). Following electropho-
resis, gels were washed twice at room temperature for 30
minutes in 2.5% Triton X-100 (Sigma Chemical Co., St. Louis,
MO, USA), subsequently washed in buffer containing 50 mM
Tris-HCl, 150 mM NaCl, 5 mM CaCl2, 1 mm ZnCl2, and 0.02%
NaN3 at pH 7.5, and then incubated in this buffer at 37
C
for 24 hours. Thereafter, the gels were stained with 0.5%
(w/v) Coomassie brilliant blue G-250 (Bio-Rad) for 1 hour
and then lightly destained in methanol:acetic acid:water
(3:1:6). Clear bands appear on the Coomassie stained blue
background in areas of gelatinolytic activity. Gels were
scanned and images were processed by extracting the blue
channel signal, converting it to black and white, and then
inverting it for quantification of gelatinolytic activities from
the integrated optical density [30].
Figure 1 Effects of ethanol extracts of G lucidum (EGL) on
the cell viability in AGS human gastric carcinoma cells. The
cells were seeded at an initial density of 2.5 105 cells per 60-
mm plate, incubated for 24 hours, and then treated with
various concentrations of EGL for 48 hours. The cell viability
was measured using an MTT assay. Each point represents the
mean SD of three independent experiments. Significance was
determined using a Student t test. * p< 0.05 versus untreated
control.
Table 1 Sequences of the primer pairs employed in the
RT-PCR.
Name Sequence of primers
TIMP-1 sense 50-TGG-GGA-CAC-CAG-AAG-
TCA-AC-30
antisence 50-TTT-TCA-GAG-CCT-TGG-
AGG-AG-30
TIMP-2 sense 50-GTC-AGT-GAG-AAG-GAA-GTG-
GAC-TCT-30
antisence 50ATG-TTC-TTC-TCT-GTG-ACC-
CAG-TC-30
MMP-1 sense 50-GAT-GTT-CAG-CTA-GCT-
CAG-GAT-30
antisence 50-AAG-GGA-TTT-GTG-CGC-
ATG-TAG-30
MMP-2 sense 50-CTT-CTT-CAA-GGA-CCG-
GTT-CAT-30
antisence 50-GCT-GGC-TGA-GTA-GAT-
CCA-GTA-30
MMP-7 sense 50-GGC-CCT-GTC-ACT-CCT-
GAG-AT-30
antisence 50-GGC-ATC-CAG-GTT-ATC-
GGG-GA-30
MMP-9 sense 50-CGG-AGC-ACG-GAG-ACG-
GGT-AT-30
antisence 50-TGA-AGG-GGA-AGA-CGC-
ACA-GC-30
claudin-1 sense 50-TCA-GCA-CTG-CCC-TGC-
CCC-AGT-30
antisence 50-TGG-TGT-TGG-GTA- AGA-
GGT-TGT-30
claudin-2 sense 50-ACA-CAC-AGC-ACA-GGC-
ATC-AC-30
antisence 50-TCT-CCA-ATC-TCA-AAT-
TTC-ATG-C-30
claudin-4 sense 50-TGG-ATG-AAC-TGC-GTG-
GTG-CAG-30
antisence 50-GAG-GCG-GCC-CAG-CCG-
ACG-TA-30
E-cadherin sense 50-GAA-CAG-CAC-GTA-CAC-
AGC-CCT-30
antisence 50-GCA-GAA-GTG-TCC-CTG-
TTC-CAG-30
snail sense 50-TAT-GCT-GCC-TTC-CCA-
GGC-TTG-30
antisence 50-ATG-TGC-ATC-TTG-AGG-
GCA-CCC-30
GAPDH sence 50-CGG-AGT-CAA-CGG-ATT-TGG-
TCG-TAT-30
antisence 50-AGC-CTT-CTC-CAT-GGT-GGT-
GAA-GAC-30
GAPDHZ glyceraldehyde-3-phosphate; MMPZmatrix metal-
loproteinase; TIMPZ tissue inhibitors of metalloproteinase.
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All data are presented as mean SD. Significant differences
among the groups were determined using the unpairedStudent t test. A value of p< 0.05 was accepted as an
indication of statistical significance. All of the figures shown
in this article were obtained from at least three indepen-
dent experiments.3. Results3.1. Inhibition of cell viability by EGL treatment in
AGS cells
To determine if EGL decreases cell growth, AGS cells were
incubated with various concentrations of EGL and the cell
viability was then measured by an MTT assay. As shown in
Fig. 1, after 48 hours of EGL treatment, low concentrations
of EGL (0.25-1.00%) did not reduce cell proliferation,
whereas a high concentration of EGL (1.5%) significantly
caused a decrease in cell viability. When compared with the
control, treatments with 1.0% and 1.5% of EGL caused
approximately 6.5% and 21.5%, respectively, inhibition of
cell growth.3.2. Inhibition of cell migration by EGL in AGS cells
Low concentrations of EGL (less than 1.0%) did not affect
cell viability and did not induce apoptotic cell death (data
not shown), whereas high concentrations were cytotoxic.
Therefore, we applied 0.5% and 1.0% of EGL for the optimal
treatment concentrations to investigate whether EGL
decreases the activity of cell migration and the invasion of
AGS cells. Results of the migration assay demonstrated that
treatment with 0.5% and 1.0% of EGL time-dependently
delayed cell motility when compared with the controls
(Fig. 2).
Figure 2 Inhibition of cell motility by ethanol extracts of G lucidum (EGL) in AGS cells. Cells were grown to confluency on 30-mm
cell culture dishes and then a scratch was made through the cell layer with a pipette tip. After washing with phosphate buffered
saline serum-free media (to prevent cell proliferation) containing either vehicle or EGL (0.5% or 1.0%) was added for the indicated
tines. Photographs of the wounded area were taken for evaluation of cell movement into the wounded area.
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Using a Boyden chamber invasion assay, we next examined
if EGL decreases the activity of cell invasion. As shown in
Fig. 3, EGL treatment markedly reduced cell invasion
through the Matrigel chamber in a concentration-dependent
manner. This suggests that the inhibitory effects of cell
migration are associated with the inhibition of invasive
activity in AGS cells.
3.4. Induction of TIMP-1 and TIMP-2 expression by
EGL in AGS cells
Because migration influences metastasis and the invasion of
the basement membrane is primarily mediated by the
gelatinase MMPs and their inhibitors (TIMPs), we tested
the effects of EGL on the levels of TIMP-1 and TIMP-2. The
results of reverse transcription PCR (RT-PCR) showed that
EGL concentration-dependently increased TIMP-1, as wellas TIMP-2 mRNA levels. This was connected with a concur-
rent upregulation of their protein levels (Fig. 4), suggesting
that the increased protein expression of TIMPs by EGL could
inhibit the activity of MMPs.3.5. Inhibition of the expression and activity of
MMP-2 and MMP-9 by EGL in AGS cells
We next investigated the effects of EGL treatment on the
levels of MMPs and their activities. The results of RT-PCR
showed that EGL decreased MMP-2 and MMP-9 mRNA levels
in a concentration-dependent manner without the alter-
ation of other MMPs, such as MMP-1 and MMP-7 (Fig. 5A). In
addition, we performed the gelatin zymographic analysis to
examine whether the inhibitory effects on the mRNA levels
of MMP-2 and MMP-9 were associated with the down-
regulation of their activities. As indicated in Fig. 5C, EGL
concentration-dependently decreased MMP-2 and MMP-9
activities, which was also connected with a concurrent
Figure 3 Effects of ethanol extracts of G lucidum (EGL) on cell invasion in AGS cells. (A) Cells pretreated with the indicated
concentrations of EGL for 6 hours were plated onto the apical side of Matrigel-coated filters in a serum-free medium containing
either vehicle or EGL. Medium containing 20% FBS was placed in the basolateral chamber to act as a chemoattractant. After
48 hours, the cells on the apical side were wiped off using a cotton-tipped swab Next, the cells on the bottom of the filter were
stained using hematoxylin and Eosin Y and then counted. (B) Data are shown as the mean of triplicate samples and represent the
invasive cell numbers compared with those of control cells. * p< 0.05 versus untreated control.
230 K.-J. Jang et al.downregulation of their protein levels (Fig. 5B). These
results suggest that the anti-invasive effect of EGL is
associated with increased TIMP-1 and TIMP-2 levels, as well
as the inhibition of MMP-2 and MMP-9 levels, and their
activity in AGS cells.3.6. Enhancement of the tightening of TJs by EGL
in AGS cells
To examine the relationship between the tightening of TJS
and the invasive activity of AGS cells treated with EGL, TER
(a measure of TJ formation) values were measured using an
EVOM Epithelial Tissue Voltohmmeter (World Precision
Instruments). As shown in Fig. 6, the incubation of cells
with EGL substantially increased their TER values in
a concentration-dependent manner, suggesting that EGL
increased TJs function in AGS cells.3.7. Modulation of TJs-related factors by EGL in
AGS cells
To elucidate the mechanism by which EGL enhances TJs
activity and reduces invasive activity in AGS cells, we
determined the levels of TJs and AJs components, as well
as TJ regulators, such as claudins, E-cadherin, and snail,
using RT-PCR and western blot analyses. As shown in Fig. 7,
both the transcriptional and translational levels of claudins
(claudin-1, claudin-2, and claudin-4), the most important
components of the TJ [31], were markedly downregulated
in EGL-treated cells in a time-dependent manner, sug-
gesting that this modulation contributed to the tightening
of TJs. In addition, the levels of E-cadherin, a type I
transmembrane glycoprotein that regulates TJ and AJ
formation [32,33], were markedly inhibited by EGL treat-
ment. However, those of snail proteins, an epithelial to
mesenchymal transition regulator and zinc finger
Figure 4 Induction of tissue inhibitors of metalloproteinases
(TIMPs) expression by ethanol extracts of G lucidum (EGL) in
AGS cells. (A) Cells were treated with the indicated concen-
trations of EGL for 48 hours. Total RNAs were isolated and
reverse transcribed. Resulting cDNAs were then subjected to
polymerase chain reaction (PCR) and the reaction products
were subjected to electrophoresis on a 1% agarose gel and
visualized by ethidium bromide staining. GAPDH was used as
an internal control. (B) Cells grown under the same conditions
as (A) were sampled, lysed, and 50 mg of proteins were
separated by electrophoresis on sodium dodecyl sulfate-
polyacrylamide gels. Western blotting was then performed
with anti-TIMP-1 and anti-TIMP-2 antibodies and an enhanced
chemiluminescence detection system. Actin was used as an
internal control. The relative increase ratios of expression in
the results of the RT-PCR and western blotting were presented
at the bottom of each of the results as relative values of the
GAPDH and actin expression.
Figure 5 Inhibition of matrix metalloproteinases (MMPs)
expression and activity by ethanol extracts ofG lucidum (EGL) in
AGS cells. (A) Cells were treated with the indicated concentra-
tions of EGL for 48 hours. Total RNAs were isolated and reverse
transcribed. Resulting cDNAs were subjected to polymerase
chain reaction (PCR), and the reaction products were electro-
phoresized on a 1% agarose gel and then visualized by ethidium
bromide staining. GAPDH was used as an internal control. (B)
Cells grown under the same conditions as (A) were lysed and
50 mg of proteins were separated by electrophoresis on sodium
dodecyl sulfate-polyacrylamide gels. Western blotting was then
performed with anti-MMP-2 and anti-MMP-9 antibodies and an
enhanced chemiluminescence detection system. Actin was used
as an internal control. (C) After incubation with EGL under the
same conditions as those of (A), the medium was collected, and
the activities of MMP-2 and MMP-9 were measured by zymog-
raphy as described in Section 2. The relative ratios of expression
in the results of the RT-PCR andwestern blottingwere presented
at the bottom of each of the results as relative values of the
GAPDH and actin expression.
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dependently increased.
4. Discussion
Metastasis is a major barrier to the treatment of cancer and
a single event that results in the death of most patients
with cancer. Metastasis is the sequential multistep process
of the spread of cancer cells and the formation of new
tumors in tissues and organs beyond where the original
tumor was found. The process ultimately leads to the
outgrowth of cancer from one organ to another. Because
cancer cell invasion and migration are crucial steps during
Figure 6 Increase of transepithelial electrical resistance
(TER) values by ethanol extracts of G lucidum (EGL) in AGS
cells. Cells were treated with the indicated concentrations of
EGL for 48 hours, and TER values were measured using an EVOM
Epithelial Tissue Voltohmmeter as described in Section 2.
Results are shown as the mean SD of three independent
experiments. Significance was determined using a Student t
test. * p< 0.05 versus untreated control.
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drugs. The aim of this study was to investigate whether G
lucidum extract has potent anti-invasion and antimetastasis
activities in human gastric adenocarcinoma AGS cells. We
found that EGL markedly inhibited cell motility and invasive
activity through tightening TJs and decreasing MMP activity.Figure 7 Effects of ethanol extracts of G lucidum (EGL) on the e
Cells were treated with the indicated concentrations of EGL for 48
the indicated primers. Resulting cDNAs were subjected to polym
electrophoresized on a 1% agarose gel and then visualized by ethidiu
Cells grown under the same conditions were lysed and equal am
sulfate-polyacrylamide gel electrophoresis and transferred to ni
indicated antibodies and an enhanced chemiluminescence detecti
ratios of expression in the results of the RT-PCR and western blo
relative values of the GAPDH and actin expression.Endopeptidase MMPs are important proteolytic enzymes
during organ development and tissue regeneration;
however, they also play important roles in cancer invasion
and metastasis. Above all, MMP-2 and MMP-9 play important
roles in tumor invasion and angiogenesis; therefore, tumor
metastasis can be inhibited by blocking MMP synthesis and
activity [6,7]. Many researchers have reported that the
antimetastatic actions of natural products, including
phytochemical agents, were associated with a reduction in
MMP-2 and MMP-9 activity [36e39]. MMP activity is tightly
controlled by transcriptional activation, a complex
proteolytic activation cascade, and an endogenous system
of TIMPs. TIMPs inhibit the MMPs by forming 1:1 stoichio-
metric complexes to regulate matrix turnover [9,35].
Because treatment with less than 1.0% of EGL, which
was not cytotoxic as determined by MTT assay, markedly
inhibited the cell motility and invasive activity in AGS cells,
we investigated whether the inhibitory effects of EGL were
associated with the expression modulation of TIMPs and
MMPs or changes in their activities. Our results indicated
that EGL induced a marked inhibition of MMP-2 and MMP-9
mRNA and protein levels, as well as their enzymatic activ-
ities, in a concentration-dependent manner. By contrast,
the results of RT-PCR showed that EGL induced a concen-
tration-dependent increase of TIMP-1, as well as TIMP-2
mRNA levels, which was connected with concurrent upre-
gulation of their protein levels, as determined by western
blotting. The present data demonstrated that the EGL-
induced inhibition of cell motility and invasion is related to
downregulation of MMP-2 and MMP-9 activities through the
elevation of TIMP expression. Therefore, our results suggest
that EGL may increase the TIMPs/MMPs ratio, a key factor inxpression of claudins, E-cadherin, and snail in Hep3B cells. (A)
hours. Total RNAs were isolated and reverse transcribed using
erase chain reaction (PCR), and the reaction products were
m bromide staining. GAPDH was used as an internal control. (B)
ounts (50 mg) of cell lysate were resolved by sodium dodecyl
trocellulose. Western blotting was then performed with the
on system. Actin was used as an internal control. The relative
tting were presented at the bottom of each of the results as
Figure 8 Putative antimetastatic mechanism induced by
ethanol extracts ofG lucidum (EGL) in AGS cells. EGL inhibits cell
motility and invasion of AGS cells via tightening of tight junctions
and inhibition of the activity of matrix metalloproteinases.
Anti-invasive activity of G lucidum 233regulating the antimetastatic process, which may then
subsequently block the degradation of ECM and lead to the
inhibition of cell invasion.
Recently, increasing evidence has indicated that the
suppression of the malignant phenotype of cells in tumor-
igenesis is an additional and important function of the TJs
[3]. Moreover, it is becoming increasingly clear that the
development of human cancer is frequently associated with
the failure of epithelial cells to form TJs and to establish
correct apicobasal polarity [40]. This suggests that changes
in permeability properties and the loss of cell polarity are
hallmarks of epithelial cell tumorigenesis. Thus, it has been
demonstrated that TJs, the structures crucial for the
maintenance of these functions in epithelial cells, are
modulated in a number of epithelial cancers, including
gastric cancer [10,11]. These observations indicate that the
disruption of the TJ and the dysregulation of its composite
proteins play crucial roles in cancer progression, invasion,
and metastasis.
Indeed, early studies have demonstrated that the
structures of TJ are altered in many epithelial cancers. For
example, Soler et al. [10] first demonstrated that the TER
of colon carcinoma tissue was significantly lower than that
of normal colon tissues but showed higher transepithelial
paracellular permeability, which confirmed the loss of the
TJs. Other studies have shown that many anticancer agents
are inhibitory to motility and invasiveness and that they act
by enhancing transepithelial paracellular permeability
[29,38,41,42]. In the present study, our results clearly
showed that treatment with EGL increased the TER values
of AGS cells in a dose-dependent manner: an effect asso-
ciated with the inhibition of motility and invasiveness.
These results indicate that EGL may prevent or reverse TJ
leakiness.
Because TJ leakiness is associated with cancer progres-
sion and invasion, TJ tightening may have antimetastatic
activity [43]. The anti-invasive activity of EGL may be due,
in part, to its ability to enhance TJ activity. TJ structure is
representative of the conglomerate of molecules that
constitute, associate with, or regulate TJs. A number of
proteins, as components of TJs, were identified. Among
these, 24 members of the claudin family were identified.
Claudins are transmembrane proteins with extracellular
domains. They form homodimers or heterodimers with
other claudins to produce paired strands between cells to
regulate paracellular permeability [12].
Previous evidence has indicated that the disruption of
TJs, with the concomitant dysregulation of TJ proteins, is
an early event in cancer cell invasion and metastasis, and
the nature of the dysregulation is highly cancer type-
specific. For example, claudin-1 and claudin-7 are down-
regulated in invasive ductal carcinomas of the breast, as
well as in most established breast cancer cell lines [44].
However, claudin-3 and claudin-4 are overexpressed in
breast cancers [31,44,45], and other cancers, including
gastric [46], ovarian [47], and pancreatic cancer [48].
Conversely, “knockdown” of these two claudins (claudin-3
and claudin-4) inhibited the invasiveness of cancer
cells [49].
We also recently showed that claudin-1 plays a causal
role in the acquisition of invasive capacity in human liver
cells, which was associated with increased expression ofMMP-2. However, small interfering RNA targeting of
claudin-1 in invasive hepatocellular carcinoma cells
completely inhibited cell invasion [50]. These observations
indicate that claudins are dysregulated in many types of
cancers and may prove to be useful as biomarkers for the
detection and diagnosis of certain cancers.
Interestingly, Miyamori et al. [51] reported that claudin
promotes the activation of proMMP-2 mediated by
membrane-type MMPs. In another study, Agarwal et al.
[49] reported that the overexpression of claudin-3 and
claudin-4 proteins is associated with increased MMP-2
activity. In addition, Ip et al. [52] showed that the down-
regulation of claudin-10 reduced MMP activity in human
hepatocarcinoma cells. These reports imply a close rela-
tionship between MMP activity, the overexpression of
claudin, and the metastasis of cancer cells. Therefore, we
investigated the effects of EGL on various levels of claudin
family members, and the data showed that EGL signifi-
cantly inhibited the expression of claudin proteins, such as
claudin-1, claudin-2 and claudin-4 at both the transcrip-
tional and translation levels. The data suggest that the
anti-invasive activity of EGL is associated with the tight-
ening of TJs through the downregulation of claudin family
members.
In addition to TJs, cellecell adhesion in epithelial cell
sheets is also maintained through AJs. Thus, we further
examined the effect of EGL on the expression levels of
a major AJ component, E-cadherin, which is altered or
dysregulated in various carcinomas and known to regulate
partially the TJ formation [53]. We also investigated the
question of whether EGL induced alteration of the levels of
snail, an epithelial to mesenchymal regulator, which can
lead to decreased cellecell adhesion and increased cell
invasiveness in conjunction with the loss of E-cadherin
expression in many types of human cancers [34,35]. As
indicated in the results, the levels of E-cadherin
were gradually downregulated by EGL treatment in
234 K.-J. Jang et al.a concentration-dependent fashion. However, those of
snail were dose-dependently induced in EGL-treated AGS
cells. Although we need to validate this study, we tenta-
tively suggest that EGL, through effects on expression of
these proteins, may mediate antimetastasis and anti-
invasiveness in AGS cells.
Based on our present data, we suggest a model, as
shown in Fig. 8, to explain the EGL-inhibited cell migration
and invasion mechanisms in AGS cells. The present results
revealed that EGL has an antimetastatic property, which is
accompanied by the tightening of TJs and the repression of
MMPs activities while concurrently inhibiting claudin
expression, as well as inducing TIMPs expression. Our find-
ings point to a novel anticancer mechanism by which
G lucidum extracts, and the results also indicate that
G lucidum extracts may be a promising new dietary source
for decreasing the risk of developing gastric cancer.
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